Impact of Induction Therapy on Preventing Early Acute Kidney Allograft Rejection: A Single-Center Experience Study
Acute rejection within two weeks post-transplantation has been associated with suboptimal graft function in recipients with low immunological risk. Basiliximab does not provide additional advantages in preventing early acute rejection in patients with a low immunological risk on tacrolimus-based immunosuppression.
Authors
- Gizem Kumru (ORCID: https://orcid.org/0000-0001-7529-3010)
Institutions
- Ankara University (TR)
Publication Details
- Journal
- Journal of Clinical Practice and Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14744/cpr.2025.15284
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00